An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2012
At a glance
- Drugs Valaciclovir (Primary)
- Indications Herpes simplex virus infections
- Focus Pharmacodynamics
- 01 Dec 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 09 Feb 2010 New source identified and integrated (University of Washington Health Sciences record no. 37304).
- 06 Feb 2010 New trial record